This study examined test-retest reliabilities of setf-reported human immunodeficiency virus (HIV) sexual and drug injection behaviors among 246 prior drug users admitted to either of two residential drug treatment programs in Westborough, Massachusetts, and Providence, Rhode Island, between June 1990 and September 1992. Participants, selected by their date of admission, were administered admission and reliability questionnaires pertaining to HIV risk behaviors, the latter at approximately 2 weeks after admission. Estimated reliabilities (kappa coefficients) of the sexual behaviors ranged from 0.72 to 0.91; those for the drug injection variables ranged from 0.63 to 0.98. These results were consistent across groups defined by sex and injection of drugs. The consistently good reliabilities are significant to the design of independent studies of drug treatment populations utilizing self-report measures of sexual and drug behaviors. Am J Epidemiol 1996; 143: 725-32.
Drug-using populations are at risk of human immunodeficiency virus (HTV) infection through risky sexual activities with an infected partner and through the use of contaminated injection paraphernalia. In the United States, it is estimated that between October 1992 and September 1993, there were 26,000 new cases of HTV infection attributable to sharing of injection paraphernalia and an additional 3,576 attributable to heterosexual sexual activities with an injecting drug user (1) . Thus, the elimination of risky behaviors is critical for the prevention of HTV infection. The evaluation of HTV risk requires the availability of reliable indices of sexual and drug injection behaviors that are easily measured. Biologic markers of drug use such as urinalysis or radioimmunoassay of hair or sexually transmitted disease incidence studies as markers of sexual behaviors are still of questionable validity. Thus, self-report is often the only practical means of assessing these behaviors.
The reliability of self-reported drug use has been evaluated by several authors (2) (3) (4) (5) . Instruments that measure specific HTV risky drug behaviors have also been developed and validated (6) (7) (8) (9) (10) . However, few studies have focused on the reliability of self-report of specific HTV risky drug behaviors.
Darke et al. (11) created an HTV-related risk-taking behavior scale, a brief 11-item, interviewer-administered scale that examines the injecting and sexual behaviors of injection drug users. Its reliability was assessed in 64 subjects enrolled in opiate treatment; the interval between the test and retest was 1 week. The Pearson's product-moment correlation coefficient for the total score (injection and sexual behavior) was r -0.86. Reliability coefficients for either the sexual or drug behavior scores separately, or for each sexual or drug behavior item, were not reported.
Volavka et al. (12) developed a 13-item questionnaire (10 items of which focused on sexual and drug behaviors) to assess risk factors for HTV infection and administered it to 476 patients admitted to a psychiatric hospital. Both interrater and test-retest reliabilities were estimated. The interval between the test-retest evaluations ranged from 15 to 52 days. Individual items were not evaluated separately. Instead, they were used to classify subjects in two risk categories (low and high). Test-retest reliability analysis yielded an estimated kappa statistic of 0.62, with 81 percent agreement found. " There have been fewer reliability studies of selfreported sexual behaviors, and they have been generally limited to non-drug-using populations, such as college students and homosexually active men (13) . Wide ranges of reliability values have been found, and several studies have also highlighted the social stigma of certain behaviors (14) (15) (16) . One study suggested that sexual behaviors in injection drug users are measured less reliably in respondents who are Hispanic or black, in those with less formal education, and in females with a lower perceived self-efficacy (17) . Injection drug users are also more likely to have a history of psychiatric problems compared with the general population or groups of homosexual men (18) , and this attribute may be associated with a lower reliability of self-reported sexual behavior. Indeed, some researchers have concluded that injection drug users are more reliable in the reporting of drug use behaviors than of sexual behaviors (18, 19) .
For the above reasons, additional evaluations of the reliabilities of various risky sexual behaviors and injection patterns using test-retest study designs are needed (20) (21) (22) . Project IMPACT is a National Institute of Drug Abuse-funded study of the effectiveness of therapeutic community and relapse prevention residential programs for treating drug users. Included in the study design were reliability assessments of selected HTV risk behaviors at approximately 2 weeks after admission. This study examined the reliability of these behaviors among 246 clients who provided test and re-test interviews within 4 to 27 days of each other.
MATERIALS AND METHODS Sample
The analysis sample was drawn from Project IMPACT, a research study comprised of two concurrent randomized trials of alternative residential drug use treatments of different durations. In the first trial, subjects were randomized to either a 6-or a 12-month therapeutic community program. In the second trial, subjects were randomized to either a 3-or a 6-month modified therapeutic community called "relapse prevention." Details of the study design are described elsewhere (23) . Enrollment occurred during the 27-month period between June 15, 1990 and September 5, 1992. There were a total of 873 admissions at both sites, and after consent was requested and exclusion criteria were applied, the final sample was 711 (81 percent of all admissions).
A subsample of 301 clients, determined by date of admission, was scheduled for the administration of a reliability questionnaire pertaining to HTV risk behaviors at approximately 2 weeks after admission. The remaining subjects were administered reliability inter-" views for the evaluation of other key variables and are described elsewhere (24) . Interviewers were trained and monitored according to a written protocol that included instrument-specific instructions, role playing, observation, and periodic reviews of taped interviews.
Study variables
A behavioral risk assessment instrument, a modification of the instrument developed for another research study, Project SMART (25) , was used to inquire about several HTV risky sexual behaviors during the 3 months prior to admission, including specific sexual activities such as the number of same-and opposite-sex partners; the number of partners with whom oral, vaginal, and anal sexual activities were performed; frequency of condom use; and frequency of sexual activity under the influence of drugs or alcohol. We report on four sexual behavior variables. Three were composite summaries derived from principal components analysis: number of opposite or male same-sex partners, drug-injecting sexual partner risk score, and a condom use composite variable. Number of opposite or male same-sex partners is the sum of opposite sexual partners plus, for males only, the number of male sexual partners (1, 2-4, 5-9, or 10 or more). The drug-injecting sexual partner risk summary is an index of any sexual activity with opposite or male same-sex partners who were drug injectors (none, some). The condom use composite scale has five levels ranging from no vaginal or anal sexual activity to any unprotected anal sexual activity (no vaginal or anal sex; always condoms with vaginal sex and/or anal sex; sometimes condoms with vaginal sex, no unprotected anal sex; no condoms with vaginal sex, no unprotected anal sex; unprotected anal sex). The remaining sexual behavior variable was a dichotomous variable taken directly from the questionnaire: any sexual activity in the 3 months prior to admission (no, yes).
The five drug behavior variables measure different aspects of drug use: injection history, frequency of needle sharing, frequency of needle lending, number of sharing partners, and a composite risky injection behavior variable. All but the injection history variable are composite variables. Four variables are ordinal measures of HTV risky drug behavior to summarize information from several questionnaire items regarding specific behaviors. For "composite risky injection behavior," we summarized needle use, needle sharing, and bleaching of equipment into a single five-category measure, with categories ranging from no recent injection drug use to injection drug use with previously used needles and never cleaning with bleach (no recent injection; no sharing; sharing, always bleach; sharing, some bleach; sharing, never bleach). This variable was developed for use in Project SMART (26) . The other three composite variables, measuring frequency of sharing, lending (no recent lending, rarely, less than 50 percent of the time, more than 50 percent of the time, usually, always) and number of sharing partners (0, 1, Reliability of Self-reported HIV Risk Behaviors 727 2, 3, 4-6, 7 or more), were obtained by combining variables that measured the presence of each behavior (sharing partners, lending) and the frequency of such behaviors.
Demographic measures included sex, education, race/ethnicity, and site of enrollment. Additional control variables included the Beck Depression Inventory, used to assess depressive symptomatology (27) , and the Jackson social desirability scale from the Jackson Personality Research Form, used to assess the extent to which subjects' responses might be biased by social desirability (28) .
Statistical methods
Preliminary analyses were performed to assess selection bias and compared completers of the reliability interview with the rioncompleters with respect to sex, race, and education. Comparisons were also made using type of treatment, self-report of sexual activities in the 3 months prior to admission, injection drug use in the 3 months prior to admission, and frequency of sharing "works."
Analyses of reliability assessed evidence of trend over time in self-report and, in the absence of trend, reproducibility. McNemar's tests were performed to assess time trends in responses between the admission and reliability interviews. Test-retest reliabilities were estimated by using the generalized kappa statistic (29) . This statistic is an extension of Cohen's kappa statistic (30) , originally defined as a chance corrected measure of agreement for use with dichotomous measures. The generalized kappa is a ratio comparison of the observed "distance" between measures and that expected by chance, with chance and perfect agreement having kappa values equal to zero and one, respectively. It is therefore appropriate for both discrete and interval data. For dichotomous outcomes in the test-retest setting, the generalized and Cohen's kappa statistics are identical and equivalent to the intraclass correlation coefficient. More generally, empirical studies of the generalized kappa statistic for other types of variables suggest that it is a more conservative measure of agreement than the intraclass correlation coefficient (31) .
For one of the sexual behavior variables, "any sexual contact during the 3 months prior to admission," the entire sample was used. Reliability analyses of the other sexual behavior variables were carried out only for the subset that reported any sexual contact at the admission interview. Similarly, injection history was examined using the entire reliability sample, whereas the reliability of the composite variable summarizing risky injection behavior and the variables measuring injection patterns were examined only in the subset that reported any recent injection drug use at admission, since these variables are only relevant to subjects who are recent drug users.
RESULTS

Reliability sample
The study design called for the administration of the admission interview on the day of entry into treatment and of the reliability interview on the fourteenth day after admission. A total of 301 subjects were enrolled during the periods designated for this reliability study; of these, 247 (82.1 percent) completed both the initial and the retest interviews. The remaining 54 included seven (2.3 percent) subjects with missing admission interviews (early dropouts from the programs), plus 47 (15.6 percent) who left the treatment programs after the admission interview but before the retest.
A total of 164 (66.6 percent) subjects had intervals between interviews of less than 14 days due to the delay in administering the admission interview . Thirty (12.2 percent) subjects were in the programs for more than a week before they were administered the admission interview, and only 10 (4.1 percent) were in the program for more than 10 days before they had the admission interview. The interval between the admission and reliability interviews ranged from 4 to 27 days with one additional person having a lag of 35 days. Since we suspected this outlier to be nonrepresentative of the rest of the sample, we excluded this subject. The analysis sample in this report is therefore comprised of 246 subjects. The majority (n = 168, 68.0 percent), had their reliability interview between 10 and 18 days from their admission interview.
Baseline characteristics
Subjects scheduled to receive the HTV risk behavior reliability interviews were similar to other project participants with respect to sociodemographic variables such as sex, race/ethnicity, and education. They were predominantly male, white, and with at least a high school education (data not shown).
Among those scheduled to receive the HTV behavioral risk reliability interview, we compared those who completed these assessments with those who did not; characteristics of completers are presented in table 1. At their initial interview, 69 percent of the reliability study population reported sexual activity in the 3 months prior to admission, and 40 percent reported injecting drugs during this period. There was a statistically significant higher frequency of sharing among those who completed the assessments than among noncompleters. At admission, 35 (35 percent) completers reported having shared works more than 50 percent 
Test/retest trends
Retest responses were often the same as the test responses, suggesting an overall pattern of good reliabity. Compared with the admission interviews, at retest, slightly more subjects reported that they were sexually active, and fewer reported the use of condoms. However, no statistically significant trends over time were found in the reporting of any individual sexual activity (table 2) .
We found no evidence of a trend over time in the reporting of HTV risky drug behaviors (table 3) . As expected, the likelihood of identical test/retest responses was greatest for individuals who, at baseline, were in the "no risk" category (for example, injection history = "never," frequency sharing = "no recent sharing," etc.). Examination of the distribution of responses in other categories revealed no time trend in the reporting of higher or lower risk at retest, relative to baseline.
Clients with higher Jackson social desirability scores tended to report more risky behaviors at admission than at retest; however, this difference did not achieve statistical significance (data not shown).
Test-retest reliabilities
The reliabilities of the sexual and drug behavior variables are presented in table 4. The reliability of the variable "sexual activity in 3 months prior to admission" was high (generalized kappa = 0.85). Among the other sexual behavior variables, those involving the recall of having had drug-injecting sexual partners and the number of male same-or opposite-sex partners had the highest generalized kappa values (generalized kappa = 0.91 and 0.83, respectively). The generalized kappa value of the condom use composite variable, while still high (generalized kappa = 0.72), was comparatively lower. Separate reliability analyses of the sexual behavior variables were also performed by sex and recency of injection drug use, with no significant changes found (data not shown).
In the entire sample, the generalized kappa measure of the reliability of injection history was excellent (generalized kappa = 0.98). In the subset of recent injectors at admission, the reliability of the composite risky injection behavior variable was moderate (generalized kappa = 0.68). Not surprisingly, the selfreported needle behaviors were less reliable, although still in the acceptable moderate range (range, 0.63-0.65).
Stratified analyses by sex of the composite risky injection behavior variable suggested similar reliabilities in both groups. However, for the variables "frequency of sharing" and "frequency of lending," females had lower generalized kappa values than did males. Conversely, males were less reliable than females in the reporting of "number of sharing partners." These differences were not statistically significant and could be an artifact of small sample sizes.
DISCUSSION
Our study is among the first reliability analyses that consider the reporting of specific HTV risk behaviors,
Reliability of Setf-reported HIV Risk Behaviors 729 in particular, frequency measures of condom use and needle sharing and lending (32, 33) . Overall estimates of the reliability of self-reported drug and needle use behaviors were moderate to excellent. The subjects in this study represented a group of prior drug users who had, if necessary, been detoxified prior to treatment admission. The high levels of reliability obtained in this setting, pertaining to subjects retained in treatment, cannot be generalized to the population of active drug users.
The relative underreporting of any sexual activity prior to admission at the test interview, while only marginally significant, is consistent with an hypothesized social stigma against risky sexual behaviors (19). This can be potentially avoided if queries about sexual behaviors are deferred until confidence with the research interviewer is gained. Interestingly, among the sexual behaviors, the lowest reliability was found for the variable measuring condom use. This may reflect the relative difficulty in recalling the details of condom use among persons with multiple sexual encounters.
With respect to self-reported drug behaviors, consideration of a variety of variable types (dichotomies to six-point ordinal scales) is of methodological significance. Variations in reliability reflect, at least in part, precision of measurement: An increase in the number of response categories represents increased precision of measurements, but at the price of greater likelihood of disagreement upon repeated measurement. Simple queries, such as injection history measured on a three-point scale, would be expected to have greater reliabilities than more detailed questions, such as frequency of sharing measured on a six-point scale. Thus, our finding of consistently good reliabilities even for scales measured on six levels is encouraging to the design of independent studies utilizing self-report measures of drug behavior for broad ranges of choice of scale. We found no pattern suggestive of social stigma.
The finding of higher Jackson social desirability scores in completers is not surprising; completers may be more likely than noncompleters to adapt to what is expected of them. The finding that noncompleters had relatively low frequencies of sharing, compared with completers, is unexpected. We had hypothesized that noncompleters, who had higher Beck depression scores and lower Jackson social desirability scores, Potential limitations to our results are sources of bias that are characteristic of studies of risk behavior, particularly those arising from consistent untruthful reporting. Good reliabilities do not necessarily reflect good validities. However, this is a common limitation of studies of this type, in which gold standards are not available. Furthermore, using the Jackson social desirability scale as our index of potentially untruthful reporting, we compared the subset who changed responses at retest versus those who did not and found little evidence of biased self-report. In only one variable (sexual activity in the 3 months prior to admission) was the Jackson social desirability scale significantly higher in subjects who had not changed their response from test to retest (data not shown).
Also a potential limitation is the possibility that estimated reliabilities vary systematically with elapsed time between the admission and reliability interviews. In our sample, the time between the test and retest interviews ranged from 4 to 27 days. While we did see evidence of reduced reliability with increasing time between the test and retest interviews, this trend was not statistically significant (data not shown). In addition, the numbers of subjects with short (less than 10 days) and long (more than 18 days) test-retest intervals were equal. Consequently, given that the majority (68 percent) had intervals of between 10 and 18 days, our results are likely to be representative of reliablities obtained during this aproximate 2-week interval. The consistently good reliabilities found in this study are significant to the design of independent studies of drug treatment populations utilizing selfreport measures of sexual and drug behaviors.
